Internal Medicine Alert - October 30, 2013

Target Audience:

This CME activity is intended for the internist/family physician.

Accreditation:

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 1.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
Internal Medicine Alert has been reviewed and is acceptable for up to 1 Prescribed credit by the American Academy of Family Physicians. AAFP accreditation begins 01/15/13. Term of approval is for one year from this date with the option of yearly renewal.

Faculty Listing:

Editor
Stephen A. Brunton, MD

Clinical Professor
University of California, Irvine

Executive Editor
Leslie Coplin

Managing Editor
Neill Kimball

Associate Editors
Allan J. Wilke, MD
Professor and Chair
Program Director
Department of Family Medicine
Western Michigan University School of Medicine
Kalamazoo

William T. Elliott, MD, FACP
Chair, Formulary Committee
Northern California Kaiser Permanente
Asst. Clinical Professor of Medicine
University of California
San Francisco

James Chan, PharmD, PhD
Pharmacy Quality and Outcomes Manager
Kaiser Permanente
Oakland, CA

Louis Kuritzky, MD

Clinical Assistant Professor
University of Florida
Gainesville

Authors
Martin S. Lipsky, MD
Adjunct Professor,
Institute on Aging,
School of Community Health,
Portland State University;
Dean Emeritus,
University of Illinois College of Medicine,
Rockford

Rahul Gupta, MD, MPH, FACP
Clinical Assistant Professor,
West Virginia University School of Medicine,
Charleston, WV

Edward P. Gerstenfeld, MD
Professor of Medicine,
Chief, Cardiac Electrophysiology,
University of California,
San Francisco

Peer reviewer
Gerald Roberts, MD
Senior Attending Physician
Long Island Jewish Medical Center
NS/LIJ Health Care System
New Hyde Park, NY

Subjects:

  • Antibiotic Use: Still Room for Improvement
  • ARBs in Diabetes - Some Good, Some Better!
  • Long-Term Results of Dabigatran vs Warfarin for Stroke Prevention in AF Patients
  • Clinical Briefs by Louis Kuritzky, MD

Objectives:

  • Describe new findings in differential diagnosis and treatment of various diseases
  • Describe the advantages, disadvantages and controversies surrounding the latest advances in the diagnosis and treatment of disease
  • Identify cost-effective treatment regimens
  • Explain the advantages and disadvantages of new disease screening procedures.

Financial Disclosure:

Internal Medicine Alert's editor, Stephen Brunton, MD, serves on the advisory board for Abbott, Amarin, Boehringer Ingelheim, Duchesnay, Janssen, Lilly, Novo Nordisk, Sunovion, and Teva; he serves on the speakers bureau of Boehringer Ingelheim, Janssen, Lilly, Novo Nordisk, and Teva. Peer reviewer Gerald Roberts, MD; executive editor Leslie Coplin; and managing editor Neill Kimball report no financial relationships relevant to this field of study.

Authors Rahul Gupta, MD, MPH, FACP,William T. Elliott, MD, FACP and James Chan, PharmD, PhD report no financial relationships relevant to this field of study.

Author Martin S. Lipsky, MD is a retained consultant for Health Solutions & Strategies.

Author Edward P. Gerstenfeld, MD does research for Biosense Webster, Medtronic, and Rhythmia Medical.